International Journal of Clinical Research

Objective To observe the improvement of clinical indicators in elderly patients with coronary heart disease in the community treated with clopidogrel combined with aspirin. Methods To conduct group comparison, this study plans to randomly select 66 elderly patients with coronary heart disease admitted to our hospital from January 2024 to October 2024. According to the drawing results, they will be divided into a control group (only receiving aspirin treatment) and an experimental group (receiving clopidogrel combined with aspirin treatment). The total effective rate and incidence of adverse reactions of the two groups of patients will be used to determine the treatment effect. Results After data analysis, it is not difficult to know that the experimental group patients not only had a higher total effective rate of treatment than the control group patients, but also had a lower incidence of adverse reactions than the control group patients (P<0.05). Conclusion The combination of clopidogrel and aspirin treatment can effectively reduce the incidence of adverse reactions in elderly patients with coronary heart disease in the community, and has a very significant effect on improving treatment efficacy.

Clopidogrel; Aspirin; Community elderly coronary heart disease